[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350604-105":59,"doc-detail-350604-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ythdf1slc39a4-signaling-axis-promotes-gastric-cancer-cell-proliferation-by-suppressing-cuproptosis-ex-vivo-and-in-vitro","YTHDF1/SLC39A4 signaling axis promotes gastric cancer cell proliferation by suppressing cuproptosis ex vivo and in vitro","","Gastric cancer remains a leading contributor to global cancer mortality, and new molecular targets are needed to improve therapy. Cuproptosis is a copper-dependent regulated cell death pathway with tumor-suppressive effects in gastric cancer. Clinical samples show elevated SLC39A4 expression associated with poor prognosis, yet its mechanism is unclear. Lentiviral experiments establish SLC39A4 gain- and loss-of-function in AGS and MKN-45 cells, demonstrating enhanced proliferation and attenuated cuproptosis by SLC39A4 overexpression. Mechanistically, the m6A reader YTHDF1 binds SLC39A4 mRNA and stabilizes its transcripts in an m6A-dependent manner. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ythdf1slc39a4-signaling-axis-promotes-gastric-cancer-cell-proliferation-by-suppressing-cuproptosis-ex-vivo-and-in-vitro/350604/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ythdf1slc39a4-signaling-axis-promotes-gastric-cancer-cell-proliferation-by-suppressing-cuproptosis-ex-vivo-and-in-vitro/350604.png","ImageObject",300,407,{"name":92,"@type":93},"Anna Hans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does SLC39A4 play in gastric cancer progression?","Question",{"text":112,"@type":113},"SLC39A4 promotes gastric cancer cell proliferation both in vitro and in vivo. Its overexpression attenuates cuproptosis, while knockdown potentiates cuproptosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is cuproptosis measured or supported in the study design?",{"text":117,"@type":113},"Cuproptosis is induced using CuCl2 and elesclomol and assessed with proliferation assays plus analyses of cuproptosis markers. Xenograft models are also used to confirm the findings.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is YTHDF1 important in regulating SLC39A4?",{"text":121,"@type":113},"YTHDF1 binds SLC39A4 mRNA and stabilizes its transcripts. Mutation of an m6A site within the SLC39A4 coding sequence abolishes YTHDF1-mediated regulation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350604,1790218635,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892332657,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www.nature.com/cgt](www.nature.com/cgt) Cancer Gene Therapy  \nARTICLE OPEN   \nYTHDF1/SLC39A4 signaling axis promotes gastric cancer cell proliferation by suppressing cuproptosis ex vivo and in vitro  \nJingying Su 1,2,3, Jihan Qi 1,3, Binhua Xu2, Jiaxin Wang 1, Ram Prasad Chaulagain 1, Hongliang Chen 1, Ning Li 1, Xinyu Jiang 1, Lingyi Xu1, Fengchun Li1, Wenli Mao 1 and Shizhu Jin 1 ✉  \n© The Author(s) 2026  \n\n| | Gastric cancer (GC) continues to be a major contributor to global cancer mortality, underscoring the need to elucidate its molecular mechanisms to develop effective therapies. Cuproptosis, a copper-dependent form of cell death, exhibits tumor-suppressive effects in GC. Clinical specimens revealed elevated expression of solute carrier family 39 member 4 (SLC39A4) in GC tissues, correlating with poor prognosis. However, the role of SLC39A4 in GC remains unclear. Using lentiviral transduction in AGS and MKN-45 cell lines, we established stable monoclonal strains with SLC39A4 overexpression and knockdown for functional studies. SLC39A4 promotes GC cell proliferation both in vitro and in vivo. CuCl2 and elesclomol treatment induced cuproptosis, which was attenuated by SLC39A4 overexpression but potentiated by SLC39A4 knockdown, as conﬁrmed through proliferation assays and cuproptosis marker analyses in cell cultures and xenograft models. Mechanistically, the m6A reader protein YTHDF1, frequently overexpressed in GC patients and known to inhibit elesclomol-induced cuproptosis, bound to SLC39A4 mRNA and stabilized its transcripts. Dualluciferase assays demonstrated that mutation of the m6A site within SLC39A4’s coding sequence abolished YTHDF1-mediated regulation. These ﬁndings establish SLC39A4 as a promoter of GC progression through cuproptosis suppression, modulated by YTHDF1 via m6A-dependent mRNA stabilization, revealing potential therapeutic targets for GC treatment.\u003Cbr>Cancer Gene Therapy (2026) 33:558–570; [https://doi.org/10.1038/s41417-026-01036-5](https://doi.org/10.1038/s41417-026-01036-5) | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n\nGraphical Abstract  \nINTRODUCTION  \nGastric cancer (GC) is a common malignant tumors [1], with over one million new cases diagnosed each year [2] . The mortality rate of GC ranks ﬁfth among all malignant tumors [3] . Although advances in medical technology have improved patient prognosis to some extent, the overall outlook remains unsatisfactory  \nbecause most patients are diagnosed at an advanced stage [4] . Exploring new therapeutic strategies and understanding the  \npathogenesis of GC are crucial for improving patient prognosis.  \nCuproptosis is a recently identiﬁed form of copper-dependent cell death, distinct from all other known regulated cell death pathways [5] . Excess intracellular Cu²⁺ can be transported to the  \n1Department of Gastroenterology and Hepatology, the Second Afﬁliated Hospital of Harbin Medical University, Harbin, China. 2Department of Endocrinology, Harbin the First Hospital, Harbin, China. 3These authors contributed equally: Jingying Su, Jihan Qi. ✉ email: [drshizhujin@hrbmu.edu.cn](drshizhujin@hrbmu.edu.cn)  \nReceived: 18 August 2025 Revised: 9 March 2026 Accepted: 16 April 2026  \nPublished online: 29 April 2026  \nmitochondria via ionophores and reduced to cuprous ion (Cu1+) . This process induces cell death by binding to the lipid components from the tricarboxylic acid cycle, promoting aggregation of lipoacylated proteins and loss of iron-sulfur cluster proteins [6]. Targeting the promotion of cuproptosis has been reported as a promising strategy to inhibit GC [7] .  \nCuproptosis-related genes (CRGs) regulate the progression of various cancers, including GC [8]. Solute carrier (SLC) family 39 member 4 (SLC39A4, ZIP4), a member of the SLC39 family, encodes membrane transporters involved in ion transport [9]. Downregulation of SLC39A4 ca","cbCaihaAHGd6zGtK","https://ap.wps.com/l/cbCaihaAHGd6zGtK","pdf",7168833,13,"English","# Introduction\n## Cuproptosis and gastric cancer context\n## SLC39A4 as a cuproptosis-related gene\n## YTHDF1 as an m6A reader in gastric cancer\n# Materials and Methods\n## Bioinformatics analysis","[{\"question\":\"What role does SLC39A4 play in gastric cancer progression?\",\"answer\":\"SLC39A4 promotes gastric cancer cell proliferation both in vitro and in vivo. Its overexpression attenuates cuproptosis, while knockdown potentiates cuproptosis.\"},{\"question\":\"How is cuproptosis measured or supported in the study design?\",\"answer\":\"Cuproptosis is induced using CuCl2 and elesclomol and assessed with proliferation assays plus analyses of cuproptosis markers. Xenograft models are also used to confirm the findings.\"},{\"question\":\"Why is YTHDF1 important in regulating SLC39A4?\",\"answer\":\"YTHDF1 binds SLC39A4 mRNA and stabilizes its transcripts. Mutation of an m6A site within the SLC39A4 coding sequence abolishes YTHDF1-mediated regulation.\"}]","YTHDF1/SLC39A4 signaling axis promotes gastric cancer cell proliferation by suppressing cuproptosis ex vivo and in vitro | PDF",1790089844,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/453a16ab76a2cf5492d1e8120a3325c2.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9588eb210fe451886c929d270ece282c.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/271eaa7be939bedb5380d209690e400b.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e307317ef50e6fcad6e48839a491376.webp",980,1301]